NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)

CompletedN/A

Sponsor: Pfizer

Conditions: Crohn's Disease, Ulcerative Colitis

Interventions: Infliximab [infliximab biosimilar 3]

Countries: Japan

To collect information on the safety and effectiveness of Infliximab BS for Intravenous Drip Infusion 100 mg "Pfizer" against Crohn's disease or ulcerative colitis under actual status of use.

Eligibility overview

Sex: ALL

Age: 0 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients with Crohn's disease or ulcerative colitis who started treatment with this drug
* Patients who received this drug for the first time at the medical institution after the day of launch of this drug.

Locations (1)

Tokyo, Japan